Viewing Study NCT05618366


Ignite Creation Date: 2025-12-24 @ 4:39 PM
Ignite Modification Date: 2026-01-25 @ 12:16 AM
Study NCT ID: NCT05618366
Status: RECRUITING
Last Update Posted: 2025-04-08
First Post: 2022-11-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
Sponsor: Weill Medical College of Cornell University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin View
None Diffuse Large B Cell Lymphoma View
None Follicular Lymphoma View
Keywords: